Sirio Pharma (300791) — Tangible Net Worth Ratio
Sirio Pharma (300791) has a Tangible Net Worth Ratio of 79.0% as of June 2025. This metric is calculated by deducting intangible assets (CN¥559.27 Million) from net assets (CN¥2.66 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Sirio Pharma (300791) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Sirio Pharma Tangible Net Worth Ratio (2016–2024)
This chart shows how Sirio Pharma's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 79.0%, reflecting net assets of CN¥2.66 Billion with intangible assets of CN¥559.27 Million CNY. See 300791 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Sirio Pharma (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Sirio Pharma from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Sirio Pharma (300791) total market value.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 78.9% | CN¥2.64 Billion | CN¥558.27 Million | CN¥5.49 Billion | ▲ +1.4 pp |
| 2023 | 77.5% | CN¥2.57 Billion | CN¥577.56 Million | CN¥5.20 Billion | ▼ -14.5 pp |
| 2022 | 92.0% | CN¥2.70 Billion | CN¥216.93 Million | CN¥4.19 Billion | ▲ +0.1 pp |
| 2021 | 91.8% | CN¥2.54 Billion | CN¥208.12 Million | CN¥3.82 Billion | ▼ -0.1 pp |
| 2020 | 92.0% | CN¥2.18 Billion | CN¥175.63 Million | CN¥2.65 Billion | ▲ +1.2 pp |
| 2019 | 90.8% | CN¥1.95 Billion | CN¥179.47 Million | CN¥2.36 Billion | ▲ +12.6 pp |
| 2018 | 78.2% | CN¥784.05 Million | CN¥171.20 Million | CN¥1.54 Billion | ▲ +8.5 pp |
| 2017 | 69.7% | CN¥580.20 Million | CN¥175.74 Million | CN¥1.29 Billion | ▲ +6.6 pp |
| 2016 | 63.2% | CN¥464.98 Million | CN¥171.31 Million | CN¥1.46 Billion | — |